US53216B1044 - Common Stock
LFMD stock results show that LifeMD beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips LifeMD (NASDAQ:LFMD) just reported results for the first quarter of 2024.LifeMD...
Stay updated with the stocks that are on the move in today's after-hours session.
First quarter revenue increased 33% year-over-year to $44.1 million with telehealth revenue growing 53% versus the year-ago period.Raising full-year...
/PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating LifeMD, Inc. (NASDAQ: LFMD) on behalf of the company's shareholders. The...
LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve...
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
Dexcom earns a lofty No. 5 rank among its peers in the 130-stock Medical-Products industry group. It got a rating upgrade Tuesday.
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the...
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will...
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its...
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management...
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.
With growing demand, the market for telemedicine stocks could be worth about $450 billion by the time 2032 rolls around.
Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period.Adjusted EPS of...
These three companies are beaten up stocks to buy, as their oversold status and solid fundamentals make them attractive picks.
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in...
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in...
LifeMD expects 2024 revenue to be $195M-$205M, exceeding analysts' expectations.
Shares of WW International (WW) and LifeMD (LFMD) fell Thursday as Eli Lilly (LLY) launched LillyDirect, an online offering for obesity drugs. Read more here.